The global medical cannabis market is expected to grow at a CAGR of around 34.5% during the forecast period, from 2021 to 2030. The growth in this market can be attributed to the increasing legalization of cannabis for medical purposes across various countries and regions. For instance, in Canada, the use of cannabis for medical purposes has been legalized since 2001 and it is now legal for patients with a prescription from their doctor to buy or grow marijuana plants. In addition, in 2018, Mexico legalized the use of marijuana for medicinal purposes and also allowed its importation into the country. This has led to an increase in demand for cannabis-based products such as oils and creams that are used by patients suffering from chronic pain or other conditions such as epilepsy or multiple sclerosis (MS). The global medical cannabis market is segmented on the basis of type into THC (tetrahydrocannabinol) and CBD (cannabidiol). THC is one of many compounds found in marijuana that offers relief from pain, nausea, anxiety disorders etc, whereas CBD does not have psychoactive effects but offers relief from inflammation-related conditions like arthritis or neurological diseases like epilepsy or MS. The application segment includes pain management applications which include chronic pain management; arthritis treatment; neurological disease applications which include epilepsy treatment; multiple sclerosis treatment; other neurological applications which include Parkinson’s disease treatment among others. North America dominates this market owing to high prevalence rates of chronic diseases such as cancer among adults aged 65 years old and above coupled with high per capita spending on healthcare services by consumers due to higher disposable income levels compared with other regions globally.
- The legalization of medical cannabis in the United States has been a major factor in the growth of this market.
- The increasing number of states legalizing medical cannabis has led to an increase in demand for this product, which is expected to drive growth over the next few years.
- Medical cannabis is used as a treatment for chronic pain, seizures, and other conditions that are difficult to treat with traditional medications or therapies.
- Medical cannabis can be used as an alternative treatment for patients who have not responded well to traditional treatments or therapies and may be more effective than other treatments available on the market today.
- There are many different types of medical cannabis products available on the market today including oils, tinctures, capsules, and edibles which offer different benefits depending on what type of condition they are being used for.
Industry Growth Insights published a new data on “Medical Cannabis Market”. The research report is titled “Medical Cannabis Market research by Types (Tetrahydrocannabinol (THC), Cannabidiol (CBD)), By Applications (Pain, Arthritis, Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications), Others), By Players/Companies BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc, Canopy Growth Corporation, Insys Therapeutics, Inc, Aphria, Inc, MGC Pharmaceuticals Limited, GW Pharmaceuticals, plc, Medical Marijuana Inc”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Medical Cannabis Market Research Report
By Type
Tetrahydrocannabinol (THC), Cannabidiol (CBD)
By Application
Pain, Arthritis, Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications), Others
By Companies
BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc, Canopy Growth Corporation, Insys Therapeutics, Inc, Aphria, Inc, MGC Pharmaceuticals Limited, GW Pharmaceuticals, plc, Medical Marijuana Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Medical Cannabis Market Report Segments:
The global Medical Cannabis market is segmented on the basis of:
Types
Tetrahydrocannabinol (THC), Cannabidiol (CBD)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pain, Arthritis, Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications), Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BOL Pharma
- Tilray
- Medreleaf Corporation
- Aurora Cannabis, Inc
- Canopy Growth Corporation
- Insys Therapeutics, Inc
- Aphria, Inc
- MGC Pharmaceuticals Limited
- GW Pharmaceuticals, plc
- Medical Marijuana Inc
Highlights of The Medical Cannabis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tetrahydrocannabinol (THC)
- Cannabidiol (CBD)
- By Application:
- Pain
- Arthritis
- Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Medical Cannabis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Medical cannabis is a plant-based substance that has been used to treat a variety of medical conditions for centuries. Cannabis is classified as a Schedule I drug by the U.S. Drug Enforcement Administration, meaning it has high potential for abuse and no currently accepted medical use in treatment in the United States. However, there are many countries around the world where medical cannabis is legal and used to treat various health conditions.
Some of the major players in the medical cannabis market are BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc, Canopy Growth Corporation, Insys Therapeutics, Inc, Aphria, Inc, MGC Pharmaceuticals Limited, GW Pharmaceuticals, plc, Medical Marijuana Inc.
The medical cannabis market is expected to grow at a compound annual growth rate of 34.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Medical Cannabis Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Medical Cannabis Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Medical Cannabis Market - Supply Chain
4.5. Global Medical Cannabis Market Forecast
4.5.1. Medical Cannabis Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Medical Cannabis Market Size (000 Units) and Y-o-Y Growth
4.5.3. Medical Cannabis Market Absolute $ Opportunity
5. Global Medical Cannabis Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Medical Cannabis Market Size and Volume Forecast by Type
5.3.1. Tetrahydrocannabinol (THC)
5.3.2. Cannabidiol (CBD)
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Medical Cannabis Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Medical Cannabis Market Size and Volume Forecast by Application
6.3.1. Pain
6.3.2. Arthritis
6.3.3. Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Medical Cannabis Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Medical Cannabis Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Medical Cannabis Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Medical Cannabis Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Medical Cannabis Demand Share Forecast, 2019-2026
9. North America Medical Cannabis Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Medical Cannabis Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Medical Cannabis Market Size and Volume Forecast by Application
9.4.1. Pain
9.4.2. Arthritis
9.4.3. Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Medical Cannabis Market Size and Volume Forecast by Type
9.7.1. Tetrahydrocannabinol (THC)
9.7.2. Cannabidiol (CBD)
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Medical Cannabis Demand Share Forecast, 2019-2026
10. Latin America Medical Cannabis Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Medical Cannabis Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Medical Cannabis Market Size and Volume Forecast by Application
10.4.1. Pain
10.4.2. Arthritis
10.4.3. Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Medical Cannabis Market Size and Volume Forecast by Type
10.7.1. Tetrahydrocannabinol (THC)
10.7.2. Cannabidiol (CBD)
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Medical Cannabis Demand Share Forecast, 2019-2026
11. Europe Medical Cannabis Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Medical Cannabis Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Medical Cannabis Market Size and Volume Forecast by Application
11.4.1. Pain
11.4.2. Arthritis
11.4.3. Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Medical Cannabis Market Size and Volume Forecast by Type
11.7.1. Tetrahydrocannabinol (THC)
11.7.2. Cannabidiol (CBD)
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Groth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Medical Cannabis Demand Share, 2019-2026
12. Asia Pacific Medical Cannabis Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Medical Cannabis Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Medical Cannabis Market Size and Volume Forecast by Application
12.4.1. Pain
12.4.2. Arthritis
12.4.3. Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Medical Cannabis Market Size and Volume Forecast by Type
12.7.1. Tetrahydrocannabinol (THC)
12.7.2. Cannabidiol (CBD)
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Medical Cannabis Demand Share, 2019-2026
13. Middle East & Africa Medical Cannabis Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Medical Cannabis Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Medical Cannabis Market Size and Volume Forecast by Application
13.4.1. Pain
13.4.2. Arthritis
13.4.3. Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Medical Cannabis Market Size and Volume Forecast by Type
13.7.1. Tetrahydrocannabinol (THC)
13.7.2. Cannabidiol (CBD)
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Medical Cannabis Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Medical Cannabis Market: Market Share Analysis
14.2. Medical Cannabis Distributors and Customers
14.3. Medical Cannabis Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. BOL Pharma
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Tilray
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Medreleaf Corporation
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Aurora Cannabis, Inc
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Canopy Growth Corporation
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Insys Therapeutics, Inc
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Aphria, Inc
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. MGC Pharmaceuticals Limited
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. GW Pharmaceuticals, plc
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Medical Marijuana Inc
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook